Kirkland & Ellis and Arnold & Porter Kaye Scholer LLP have advised Curium. Covington & Burling LLP and Ropes & Gray LLP have advised Lantheus. Curium...
Curium to Acquire Lantheus in $8 Billion Merger
UCB to Acquire Candid Therapeutics in $2.2 Billion Deal
Cooley and Wilson Sonsini Goodrich & Rosati have advised Candid Therapeutics. Covington & Burling has represented UCB. UCB, a global biopharmaceutical company, has announced a definitive...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
Equinitis’ $534.5 Million Acquisition of Notified
Covington & Burling represented Siris Capital Group, LLC in the transaction. Equiniti Group plc (EQ), a portfolio company of Siris Capital Group, LLC, announced its entry...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...